CME/CE Accredited Session
Sponsored by Industry
Click For Session Details
Session Times Listed in ET
Martin J. Abrahamson, MD, FACP
This session will cover some new data regarding treatment of type 2 diabetes: the GRADE study, SURPASS phase 3 program, the STEP program for treatment of obesity. It will also provide an update on studies using SGLT2 inhibitors and GLP 1 receptor agonists in people with type 2 diabetes and atherosclerotic cardiovascular disease or chronic kidney disease.
Associate Professor of Medicine, Harvard Medical School, Director, Division of CME, Beth Israel Deaconess Medical Center, Boston, MA
Shirah Vollmer, MD
Personality disorders are a class of mental disorders characterized by pervasive maladaptive patterns of behavior, cognition, and inner experience, exhibited across many contexts and deviating from cultural norms. These patterns are inflexible and are associated with distress and impairment. That said, the definitions are controversial. Case examples will illustrate this class of mental disorders, along with suggested non-pharmacological and pharmacological interventions.
Clinical Professor of Psychiatry, David Geffen School of Medicine at UCLA, Los Angeles, CA
An Oral CGRP Antagonist for the Acute Treatment of Migraine
Andrew Blumenfeld, MD
This product theater will focus on the commitment AbbVie has to migraine patients and discusses an oral CGRP receptor antagonist for the acute treatment of migraine.
Director, Headache Center of Southern California
Sponsored by AbbVie
Rethinking the Role of Nebulization in the Maintenance Treatment of COPD
Ryan D. Reber, DO
Join us to learn about a maintenance therapy for the treatment of COPD.
Chief of Pulmonary and Critical Care Medicine, Medical Director, Intensive Care Unit, Paoli Hospital, Clinical Assistant Professor of Medicine, Sidney Kimmel Medical College of Thomas Jefferson University
Sponsored by Viatris & Theravance Biopharma
Sammy Saab, MD, MPH, AGAF
Fatty liver has emerged as a major health concern in the United States. It is now one of the leading causes of cirrhosis, risk factor for liver cancer and indication for liver transplantation. This session will help clinicians to understand the epidemiology and risk factors of fatty liver as well as how to tailor medical care in patients with underlying fatty liver disease.
Medical Director, Pfleger Liver Institute at UCLA, Medical Director, UCLA Adult Liver Transplant Program, Chief, UCLA Transplant Hepatology, Head, Outcomes Research in Hepatology at UCLA, Professor of Medicine and Surgery, UCLA, Adjunct Professor of Nursing, UCLA, Los Angeles, CA
Vaccination Matters: Understanding and Combating Hesitancy and Disparities in Vaccination
Gregory L. Hall, MD
Vaccination is a cornerstone of preventive medicine. However, many individuals fail to receive the benefits of vaccination due to growing vaccine hesitancy and a lack of effective communication about vaccines. This is especially troubling amidst the COVID-19 pandemic, as decisions to decline COVID-19 vaccination present not only increased risk to individuals but also an immediate and massive public health risk. This public health problem is magnified in already health-disparate communities, such as those of Black and Hispanic individuals, in the United States. In this session, Dr. Robert Hopkins and Dr. Gregory Hall will address these concerns by raising PCPs’ awareness of vaccine hesitancy and their understanding of how it affects diverse populations differently. The education will provide PCPs with concrete strategies, including culturally competent communication, to overcome vaccine hesitancy in patients from all backgrounds.
Associate Professor of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH, Assistant Clinical Professor in Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, Director, Center for African American Health, Research, Education & Policy, Cleveland, OH
Supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP
Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain
Brett Smith, DO
Sponsored by AbbVie
Clinical Considerations in Coronary Artery Disease
Ted Okerson, MD, FACP, FACE
Dr. Okerson currently serves as a Sr. Field Physician within the Biopharmaceuticals US Medical Team for AstraZeneca’s Division of Cardiovascular and Metabolic Diseases. Dr. Okerson has a diverse medical and scientific background, with over 15 years of full-time clinical practice and leadership experience. For the past twenty years, he has exemplified a successful transition to industry, working as a Medical Director in various aspects of the pharmaceutical industry from clinical trial design to late phase clinical development and medical affairs for various well-known companies. In his current role, Dr. Okerson educates HCPs, works across specialties for internal collaborations, and strives to improve patient care.
Sponsored by AstraZeneca Pharmaceuticals, LP
Donald B. Levy, MD
Despite the array of products and minimal regulation, it is possible to find high quality dietary supplements and use them in a rational evidence-informed manner in the care of many primary care problems. Discussion goes beyond the management of so-called short latency deficiency syndromes taught in the past to current applications for a few common primary care problems such as anxiety, depression, emotional and physical exhaustion and insomnia. We will also identify those who may need adjuncts to their diet and useful databases to find more information.
Medical Director, Osher Clinical Center for Integrative Medicine, Brigham and Women’s Hospital, Assistant Professor of Medicine, Harvard Medical School, Boston, MA
Katherine E. Galluzzi, DO, CMD, FACOFP
Primary care patients who present with cognitive change represent a clinical challenge. Delirium must be differentiated from dementia, as delirium represents a medical emergency. In this session, potential causes of delirium, Alzheimer disease and other leading causes of dementia will be reviewed. Faculty will outline the clinical findings, screening tools, diagnostic studies, and potential therapies for cognitive decline in the geriatric patient.
Professor and Chairperson, Philadelphia College of Osteopathic Medicine, Philadelphia, PA
Helping to Protect Your Older Adult Patients From the Impact of Influenza
Edward A. Dominguez, MD, FACP, FIDSA
Medical Director, Organ Transplant Infectious Disease, Methodist Transplant Specialists
Sponsored by Sanofi Pasteur Inc.
Pauline M. Camacho, MD, FACE
Learn the latest on the diagnosis and treatment of postmenopausal osteoporosis, including the latest guidelines regarding initial choice of agents, as well as duration and sequential use of drugs.
Professor of Medicine, Director of Loyola University Osteoporosis and Metabolic Bone Disease Center, Loyola University Medical Center
"My Belly Hurts and I'm Having Bowel Problems": Stepping Up Treatment of Irritable Bowel Syndrome and Chronic Idiopathic Constipation
Philip Schoenfeld, MD, MSEd, MSc
This activity will provide an evidence-based approach to the diagnosis and management of irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC), with minimal diagnostic testing. The faculty will describe evidence-based treatment guidelines and discuss the efficacy of over-the-counter and prescription agents prioritized within the guidelines. This will help you navigate the progress from patient education to diet plus over-the-counter agents to prescription agents.
Chief (Emeritus) - Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, MI
Supported by Allergan and Ironwood Pharmaceuticals, Inc. Salix Pharmaceuticals
A Proactive Way to Treat IBS-D: Post-Marketing Information and Phase 4 Data
Gregory S. Sayuk, MD, MPH
Please join us in a clinical review of exciting Phase 4 data and the latest post-marketing information on a proactive treatment that may help your IBS-D patients. IBS-D is a chronic functional disorder of the GI system that affects approximately 16 million people.
Associate Professor of Medicine, Division of Gastroenterology, at Washington University School of Medicine, St. Louis, Missouri
Sponsored by AbbVie
Uncontrolled Asthma: Changing the Patient Experience
Matthew Mintz, MD, FACP
This session will use a case presentation to discuss the impact of uncontrolled asthma and tools for assessing asthma control as well as asthma management. Learn to identify ways to customize management of uncontrolled asthma by exploring medication options for appropriate patients.
Associate Clinical Professor of Medicine, George Washington University School of Medicine & Health Sciences, Internal Medicine and Primary Care Physician,, Private Practice in Bethesda, Maryland
Sponsored by GlaxoSmithKline
Rashmi B. Halker Singh, MD, FAHS, FAAN | Galen V. Henderson, MD | Patricia E. Greenstein, MB.BCh
What do primary care providers need to know about acute head issues? Join expert faculty as they review important questions they get asked about these topics!
Associate Professor of Neurology, Director, Headache Medicine Fellowship Program, Division of Headache Medicine, Department of Neurology, Mayo Clinic, Scottsdale, AZ
Director, Division of Neurocritical Care Assistant, Professor of Neurology, Harvard Medical School, Boston, MA
Assistant Professor, Harvard Medical School, Associate Director, BIDMC Neurology Residency Training Program, Director, Neurogenetics Clinic, Beth Israel Deaconess Medical Center, Boston, MA
Liver Disease Evaluation in Primary Care: Including Alpha-1 in Differential Diagnosis
Rajani Sharma, MD, MSc
This educational program will provide a practical overview of common liver diseases which may be encountered in Primary Care, such as NAFLD and NASH. Differentiation of less common hepatic pathology, such as alpha-1 antitrypsin deficiency, will be reviewed.
Assistant Professor of Medicine, Center for Liver Disease and Transplantation, Columbia University Irving Medical Center, New York Presbyterian Hospital
Sponsored by Takeda Pharmaceuticals U.S.A., Inc.
The Continuum of Heart Failure
Jonathan D. Rich, MD, FACC, FHFSA
The objective of this program is to discuss the pathophysiology, disease burden, and management of heart failure (HF). The program will present data on HF prevalence and health outcomes, review the implications of type 2 diabetes as a common comorbidity, and provide guidance on diagnosing HF. It will conclude with a brief overview of current treatment options for HF.
Associate Professor of Medicine, Northwestern University, Feinberg School of Medicine, Medical Director, Mechanical Circulatory Support Program, Program Director, Advanced Heart Failure and Transplant Fellowship, Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, Chicago, Illinois
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
Optimizing the Management of Iron Deficiency and Iron Deficiency Anemia in Inflammatory Bowel Disease: An Update for the Primary Care Provider
Neilanjan Nandi, MD, FACP
This session reviews the latest evidence-based data regarding iron deficiency anemia (IDA) in patients with inflammatory bowel disease (IBD) and offers practical clinical insight into the diagnosis and management of this condition. Using a case-based approach, the presenting gastroenterologist discusses the multiple factors contributing to IDA in the IBD population and shares practical strategies for coordinating care across disciplines to recognize and effectively manage patients with this common condition. The current evidence base for using oral and intravenous iron therapies effectively in practice will also be reviewed. These practical pearls and pitfalls are intended to help optimize the care of IDA in patients with IBD seen in the primary care setting.
Associate Professor of Clinical Medicine, Inflammatory Bowel Diseases Center, University of Pennsylvania, Penn Presbyterian Medical Center, Philadelphia, PA
Supported by American Regent, Inc.
Petros Levounis, MD, MA
It’s time for a down-to-earth, informative, and affirming discussion on LGBTQ+ mental health for primary care clinicians working with patients of diverse gender and sexual identities. In recent years, people have addressed these issues in a healthier, more public way, and all practitioners must be prepared to meet their patients with the knowledge, understanding, and grasp of cultural context of LGBTQ+ communities.
Professor and Chair, Department of Psychiatry, Rutgers New Jersey Medical School, Chief of Service, University Hospital, Newark, NJ
A Deeper Dive into the Use of Myrbetriq® (mirabegron) in Patients 65 and Older with OAB Symptoms of Urge Urinary Incontinence, Urgency, and Urinary Frequency
David R. Staskin, MD
In this session, we will discuss the clinical impact and physiology of overactive bladder as well as the latest perspectives on management and treatment.
Attending in Urology, St. Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, MA
Sponsored by Astellas Pharma U.S., Inc.